Cargando...

A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma

Bryostatin-1 is a macrocyclic lactone whose main mechanism of action is protein kinase C modulation. We investigated its activity as a weekly 24-h infusion in recurrent ovarian carcinoma. In all, 17 patients were recruited and 11 had chemotherapy-resistant disease as defined by disease progression w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Clamp, A R, Blackhall, F H, Vasey, P, Soukop, M, Coleman, R, Halbert, G, Robson, L, Jayson, G C
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2003
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394305/
https://ncbi.nlm.nih.gov/pubmed/14520436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601285
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!